| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/25/2002 | EP1242067A2 Calcium formate for use as a phosphorus binder and a dietary supplement |
| 09/25/2002 | EP1242064A1 Liver selective therapy |
| 09/25/2002 | EP1242051A1 Novel forms of pravastatin sodium |
| 09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
| 09/25/2002 | EP0972020B1 Insulin-like growth factor agonist molecules |
| 09/25/2002 | EP0925299B1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/25/2002 | EP0746312B1 Guanylhydrazones for treating inflammatory conditions |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371376A Substituted purin derivatives as inhibitors of cell adhesion |
| 09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines |
| 09/25/2002 | CN1371369A Substituted 3-phenyl-5-alkoxl-1,3,4-oxidazol-2-ones and their use das lipase inhibitors |
| 09/25/2002 | CN1371360A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof |
| 09/25/2002 | CN1371285A Methods and compounds for treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 09/25/2002 | CN1371280A Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 09/25/2002 | CN1371272A Cosmetic composition containing pantothenic acid |
| 09/25/2002 | CN1370843A Functions of Tob gene in central nervous system of mammol and its application |
| 09/25/2002 | CN1370585A Composite Chinese medicine prepn for treating type II diabetes |
| 09/25/2002 | CN1370572A Diabetes treating medicine |
| 09/25/2002 | CN1370564A Composite perilla oil prepn and its production process |
| 09/25/2002 | CN1370560A Intelligence growth promoting antilipenic nutritous health care soft capsule and its prepn |
| 09/25/2002 | CN1370559A Anti-senility antilipemic nutritious health care soft capsule and its prepn |
| 09/25/2002 | CN1370546A Antilipemic agent and its prepn |
| 09/25/2002 | CN1370544A Nutritious health care woodfrog egg oil caspule with blood lipoid reducing function and its prepn |
| 09/25/2002 | CN1370543A Antilipemic nutritious health care soft capsule and its prepn |
| 09/25/2002 | CN1370526A Treating method of nuclear factor-KB mediated diseases and dysfuction |
| 09/25/2002 | CN1370524A Lovamin and its prepn process |
| 09/25/2002 | CN1370429A Health food |
| 09/25/2002 | CN1091443C New imidazoline compounds, process for preparing them and pharmaceutical composition containing them |
| 09/25/2002 | CN1091363C 脂肪掺合物 Fat blend |
| 09/24/2002 | US6455734 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 09/24/2002 | US6455582 Treating cancer |
| 09/24/2002 | US6455574 Administering a combinations of amlodipine or a pharmaceutically acceptable acid addition salt thereof and atorvastatin or a pharmaceutically acceptable salt thereof for treatment of combined hypertension and hyperlipidemia |
| 09/24/2002 | US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455529 Adhesion receptor antagonists |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455517 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 09/24/2002 | US6455508 Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | CA2220458C Form iii crystalline (r-(r*,r*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 09/24/2002 | CA2220455C Novel process for the production of amorphous [r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 09/19/2002 | WO2002072888A2 Polymorphisms in the human cmoat gene and uses thereof |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072780A2 Igf antagonist peptides |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072602A2 Somatostatin antagonists |
| 09/19/2002 | WO2002072598A1 Steroids as agonists for fxr |
| 09/19/2002 | WO2002072591A2 Resveratrol-phospholipids complexes |
| 09/19/2002 | WO2002072584A2 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 09/19/2002 | WO2002072579A1 Triazolopyridines as anti-inflammatory agents |
| 09/19/2002 | WO2002072573A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent. |
| 09/19/2002 | WO2002072570A2 Non-imidazole compounds as histamine h3 antagonists |
| 09/19/2002 | WO2002072569A1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same |
| 09/19/2002 | WO2002072566A1 A lactonization process |
| 09/19/2002 | WO2002072543A2 Rxr activating molecules |
| 09/19/2002 | WO2002072539A1 Diphenyl derivatives |
| 09/19/2002 | WO2002072528A1 Fluorinated trienes and their use as rxr modulators |
| 09/19/2002 | WO2002072202A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 09/19/2002 | WO2002072149A1 Methods for reducing fat by administration of adiponectin |
| 09/19/2002 | WO2002072148A1 Compositions and methods for non-insulin glucose uptake |
| 09/19/2002 | WO2002072147A1 Medicinal compositions containing bile acid transporter inhibitor |
| 09/19/2002 | WO2002072146A2 Combination of nateglinide or repaglinide with at least one further antidiabetic compound |
| 09/19/2002 | WO2002072122A1 An anti-diabetic agent obtained from the plant humboldtia decurrens and a process for preparing the same |
| 09/19/2002 | WO2002072119A1 Salvia hispanica l. (chia) in the management and treatment of cardiovascular disease, diabetes and associated risk factors |
| 09/19/2002 | WO2002072114A2 Extracts of magnoliaceae plants and their use as anxiolytic and sedative agent |
| 09/19/2002 | WO2002072099A1 Therapeutic and/or preventive agent for diabetic ischemic heart disease |
| 09/19/2002 | WO2002072097A1 Remedies and/or preventives for diabetic ischemic heart diseases |
| 09/19/2002 | WO2002072092A1 Method for increasing leptin levels using nicotinic acid compounds |
| 09/19/2002 | WO2002072083A1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 09/19/2002 | WO2002072078A2 Use of sugar phosphates, amino acids, amino acid analogs, e.g. carbomethoxypropionyl cyanide for reducing weight or diabetes complications |
| 09/19/2002 | WO2002072073A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 09/19/2002 | WO2002072004A2 Implantable artificial organ and physiological monitoring system |
| 09/19/2002 | WO2002071874A2 Composition improving age-related physiological deficits and increasing longevity |
| 09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
| 09/19/2002 | WO2002055663A3 Srebp pathway modulation through targeting hisrs |
| 09/19/2002 | WO2002055532A3 Variant growth hormone molecules conjugated with macromolecular compounds |
| 09/19/2002 | WO2002053534A8 Vla-4 inhibitors |
| 09/19/2002 | WO2002050070A3 Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 09/19/2002 | WO2002050028A3 Substituted benzoindoles as spla2 inhibitors |
| 09/19/2002 | WO2002048154A3 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
| 09/19/2002 | WO2002033096A3 Regulation of human serine-threonine protein kinase |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002030876A3 Cyclic carboxylic acids as integrin antagonists |
| 09/19/2002 | WO2002024194A9 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002014311A3 Urea compounds and methods of uses |
| 09/19/2002 | WO2001072702A3 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/19/2002 | US20020133023 Antitumor agents, osteoporosis |
| 09/19/2002 | US20020133017 Chromatographic separation of enantiomers of lactones |
| 09/19/2002 | US20020133016 Hypoglycemic agents; antilipemic agents; antidiabetic agents |